Sequential paternal haploidentical donor liver and HSCT in EPP allow discontinuation of immunosuppression post-organ transplant.
Sarah MalkielBlayne A SayedVicky Lee NgDonna A WallJacob RozmusRichard A SchreiberFarah FaytrouniIram SiddiquiKuang-Yueh ChiangYaron AvitzurPublished in: Pediatric transplantation (2021)
Sequential liver and HSCT from the same haploidentical donor are feasible in EPP. This strategy can allow for discontinuation of immune suppression.